Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma symbols : Vrna save search
Andrew Fisher Joins Verona Pharma as General Counsel
Published: 2024-03-04 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: -6.44%
pharma
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 3.48%
H: 2.74%
C: -3.58%
pharma year update financial results
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.69%
H: 0.17%
C: -4.67%
pharma report year update financial results
Michael Austwick Joins Verona Pharma as Non-Executive Director
Published: 2024-02-01 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 2.45%
H: 1.6%
C: -1.49%
pharma
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -0.9%
H: 5.79%
C: 5.1%
pharma conference
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
Published: 2024-01-02 (Crawled : 07:00) - globenewswire.com
HTGC F | $18.46 1.15% 0.38% 660K
|
Finance
|
| O: -0.12%
H: 0.54%
C: 0.48%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -3.42%
H: 1.51%
C: -2.03%
pharma million
Verona Pharma Announces November 2023 Investor Conference Participation
Published: 2023-11-08 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.14%
H: 0.81%
C: -3.82%
pharma conference
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-02 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 1.54%
H: 6.41%
C: 3.03%
pharma update financial results
Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-10-19 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -0.52%
H: 3.8%
C: -0.82%
pharma report update financial results
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023
Published: 2023-10-06 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -0.33%
H: 2.26%
C: -0.07%
pharma update commercialization
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023
Published: 2023-10-03 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -0.52%
H: 3.7%
C: -0.19%
pharma positive copd
Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD
Published: 2023-09-11 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.92%
H: 2.37%
C: -2.17%
fda pharma drug treatment application copd
Verona Pharma to Present Additional Analysis of Phase 3 ENHANCE-1 Study in COPD at ERS International Congress 2023
Published: 2023-09-06 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.31%
H: 2.15%
C: -1.53%
pharma congress international copd study
Christina Ackermann Joins Verona Pharma as Non-Executive Director
Published: 2023-08-31 (Crawled : 06:00) - globenewswire.com
OCS | $11.78 0.0% 69K
|
n/a
|
| O: 0.98%
H: 0.52%
C: -2.46%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.7%
H: 5.96%
C: 4.29%
pharma
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-03 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.0%
H: 6.48%
C: -4.57%
pharma update financial results
Verona Pharma to Present at 43rd Annual Canaccord Growth Conference
Published: 2023-07-26 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -0.76%
H: 3.4%
C: 2.44%
pharma conference growth
Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-07-20 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.38%
H: 0.96%
C: 0.52%
pharma report update financial results
Verona Pharma Announces Publication of Phase 3 ENHANCE Data in the American Journal of Respiratory and Critical Care Medicine
Published: 2023-06-28 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.3%
H: 3.3%
C: 2.37%
pharma respiratory publication care
Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD
Published: 2023-06-27 (Crawled : 06:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: -3.53%
fda pharma drug treatment application copd
Verona Pharma to Present at Jefferies Healthcare Conference - May 24, 2023
Published: 2023-05-24 (Crawled : 07:00) - biospace.com/
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: -1.02%
H: 2.85%
C: 2.1%
pharma conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.